Fraunhofer Center for Molecular Biotechnology (FhCMB) is a division of Fraunhofer USA, Inc., a not-for-profit, research organization, whose mission is to develop safe and effective vaccines and therapeutics targeting infectious diseases and autoimmune disorders. Our 56,000 square foot research and development facility also houses a state of the art, cGMP pilot facility which uses our unique, plant-based technology to produce proteins. Two clinical trials are currently underway.
In The News
February 22, 2017
The Delaware Small Business Development Center has prevented about 600 former DuPont workers from leaving Delaware to pursue jobs in other states, said J. Michael Bowman, the organization’s director. Bowman made the remarks Tuesday afternoon at a hearing before the …
I was working at the University of Delaware in the late 2000s. I lived outside of Newark when Chrysler shut down its assembly plant and fired all 2,100 of its employees. Word of the closure started to spread in February of …